| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.mankindpharma.com | |
| Market Cap | 57,049.80 Cr. | |
| Enterprise Value(EV) | 57,511.89 Cr. | 2022-03 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 35.78 | Trailing Twelve Months Ending 2022-03 |
| Price-Earning Ratio (PE) | 39.80 | Trailing Twelve Months Ending 2022-03 |
| Industry PE | 33.51 | Trailing Twelve Months Ending 2022-03 |
| Book Value / Share | 261.55 | Trailing Twelve Months Ending 2022-03 |
| Price to Book Value | 5.44 | Calculated using Price: 1,424.15 |
| Dividend Yield | 0.00 | Period Ending 2022-03 |
| No. of Shares Subscribed | 40.06 Cr. | 400,588,440 Shares |
| FaceValue | 1 | |
| 1 Day |
|
-2.86% |
| 1 Week |
|
+4.13% |
| 1 Month |
|
|
| 3 Month |
|
|
| 6 Month |
|
|
| 1 Year |
|
|
| 2 Year |
|
|
| 5 Year |
|
|
| 10 Year |
|
| 8 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
| Return on Equity (%) | 21.61 | 25.06 | 24.28 | 23.69 | 21.06 | 33.12 | 31.51 | 26.72 | |
| Return on Capital Employed (%) | 30.32 | 36.47 | 35.49 | 33.47 | 28.49 | 43.22 | 39.97 | 33.96 | |
| Return on Assets (%) | 17.54 | 20.08 | 19.10 | 16.98 | 14.22 | 22.94 | 22.79 | 18.83 |
| Particulars | 8 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
| Shh. Funds | 2,055 | 2,257 | 2,927 | 2,881 | 2,823 | 3,485 | 4,722 | 6,155 | |
| Non Curr. Liab. | 28 | 34 | 53 | 49 | 78 | 103 | 107 | 169 | |
| Curr. Liab. | 433 | 528 | 663 | 1,296 | 1,024 | 1,251 | 1,353 | 2,623 | |
| Minority Int. | 16 | 29 | 98 | 134 | 159 | 186 | 141 | 161 | |
| Equity & Liab. | 2,532 | 2,848 | 3,741 | 4,360 | 4,084 | 5,025 | 6,324 | 9,108 | |
| Non Curr. Assets | 859 | 1,142 | 1,672 | 1,787 | 2,085 | 2,206 | 2,417 | 4,702 | |
| Curr. Assets | 1,673 | 1,707 | 2,069 | 2,574 | 1,998 | 2,820 | 3,907 | 4,407 | |
| Misc. Exp. not W/O | |||||||||
| Total Assets | 2,532 | 2,848 | 3,741 | 4,360 | 4,084 | 5,025 | 6,324 | 9,108 |
| Particulars | 8 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
| Net Sales | 3,323 | 3,944 | 4,382 | 4,949 | 4,980 | 5,872 | 6,214 | 7,782 | |
| Other Income | 76 | 71 | 108 | 72 | 53 | 104 | 171 | 196 | |
| Total Income | 3,399 | 4,015 | 4,490 | 5,021 | 5,033 | 5,976 | 6,385 | 7,978 | |
| Total Expenditure | -2,738 | -3,185 | -3,536 | -3,933 | -4,055 | -4,427 | -4,565 | -5,791 | |
| PBIDT | 662 | 830 | 953 | 1,088 | 978 | 1,549 | 1,820 | 2,187 | |
| Interest | -2 | -3 | -4 | -25 | -44 | -23 | -21 | -60 | |
| Depreciation | -39 | -43 | -31 | -46 | -69 | -99 | -119 | -167 | |
| Taxation | -177 | -244 | -290 | -329 | -264 | -382 | -399 | -522 | |
| Exceptional Items | |||||||||
| PAT | 444 | 540 | 629 | 688 | 601 | 1,045 | 1,293 | 1,453 | |
| Minority Interest | -6 | -28 | -32 | -26 | -28 | -19 | |||
| Share Associate | 1 | 2 | 0 | -3 | 10 | 12 | |||
| Other Related Items | |||||||||
| Consolidated Net Profit | 439 | 542 | 629 | 656 | 579 | 1,030 | 1,265 | 1,433 | |
| Adjusted EPS | 11 | 14 | 16 | 16 | 14 | 26 | 32 | 36 |
| Particulars | 8 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
| Cash Fr. Operatn. | 280 | 537 | 628 | 639 | 600 | 1,072 | 1,137 | 920 | |
| Cash Fr. Inv. | -348 | -152 | -625 | -505 | -444 | -439 | -1,222 | -1,369 | |
| Cash Fr. Finan. | 9 | -361 | 2 | -89 | -175 | -527 | -8 | 605 | |
| Net Change | -59 | 25 | 5 | 46 | -19 | 106 | -93 | 155 | |
| Cash & Cash Eqvt | 39 | 78 | 87 | 135 | 116 | 226 | 127 | 283 |
|
Wed, 31 May 2023
Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015 In pursuant to the provisions of Regulation 8(2) of the SEBI (Prohibition of Insider Trading) Regulations 2015 (PIT Regulations) please find enclosed herewith a copy of Code of Practice and Procedure for Fair Disclosure of Unpublished Price Sensitive Information (Fair Disclosure Code). The copy of the Fair Disclosure Code is also available on the website of the Company. |
|
Wed, 31 May 2023
Authorised Key Managerial Personnel To Determine Materiality Of An Event Or Information And Its Disclosure Pursuant to Regulation 30(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 please note that the following Key Managerial Personnel of the Company are severally authorised for the purpose of determining the materiality of an event or information to the Stock Exchange(s):1. Mr. Rajeev Juneja - Vice Chairman & Managing Director 2. Mr. Sheetal Arora - Chief Executive Officer 3. Mr. Arjun Juneja - Chief Operating Officer 4. Mr. Ashutosh Dhawan - Chief Financial Officer The following Key Managerial Personnel of the Company are severally authorised for the purpose of dissemination of material event/information to the Stock Exchange 1. Mr. Ashutosh Dhawan - Chief Financial Officer 2. Mr. Pradeep Chugh - Company Secretary & Compliance Officer |
|
Wed, 31 May 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed herewith extracts of the consolidated audited financial results for the quarter and financial year ended 31st March 2023 as published in "Business Standard" Financial Express and "Jansatta" on 31st May 2023. |
| Mon, 05 Jun 2023 |
Close Within 52 Week High Zone
|
Close Within 52 Week Low Zone
|
Close Entering 52 Week Low Zone
|
William %R Bearish
|
Bearish Harami
|
Equities
M.F.
Sectors
StockEdge Social